RxDoctor Payments Data

Kelly Walkovich

Pediatric Hematology-Oncology · Ann Arbor, MINPI 1629278171

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,832 of the $42,757 with a category attached, or 67.4%. 6 manufacturers reported payments, led by Pharming Healthcare, Inc. at 31.1% of the total.

$42,757in general payments, 2019–2025

Across 26 payments — averaging $1644.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pharming Healthcare, Inc.$13K
  • X4 Pharmaceuticals, Inc.$10K
  • AstraZeneca$8K
  • Amgen$4K
  • Sobi, Inc$4K
  • Agios Pharmaceuticals, Inc.$3K
$781,688in research payments, 2019–2025

Across 18 payments — averaging $43,427 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$562K
  • X4 Pharmaceuticals, Inc.$219K

What the payments were for

  • Consulting fees$28,83267%
  • Speaking & faculty fees$13,92533%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$42,757 in reported general payments places this provider in the 85th percentile of 84 pediatric hematology-oncology providers in Michigan.

See all pediatric hematology-oncology providers in Michigan

Other pediatric hematology-oncology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →